- Conditions
- Single-ventricle, Infant Conditions, Infant, Newborn, Diseases, Infant, Premature, Diseases
- Interventions
- PK/PD Model Based Dosing of Digoxin in Infants with Single Ventricle Heart Disease
- Drug
- Lead sponsor
- Duke University
- Other
- Eligibility
- 30 Days to 6 Months
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2026
- U.S. locations
- 2
- States / cities
- Durham, North Carolina • Charleston, South Carolina
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 97
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Infant,Premature
- Interventions
- Cardiorespiratory monitoring
- Diagnostic Test
- Lead sponsor
- University of Alabama at Birmingham
- Other
- Eligibility
- 1 Day to 15 Days
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 1
- States / cities
- Birmingham, Alabama
- Conditions
- Patent Ductus Arteriosus
- Interventions
- optimized ibuprofen, Standard Ibuprofen
- Drug
- Lead sponsor
- OSF Healthcare System
- Other
- Eligibility
- 1 Day to 29 Days
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2010
- U.S. locations
- 1
- States / cities
- Peoria, Illinois
- Conditions
- Atrial Fibrillation, Tachycardia, Bradycardia, Premature Supraventricular Beat, Premature Ventricular Contraction
- Interventions
- Cardiologs Platform
- Device
- Lead sponsor
- Cardiologs Technologies
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 220 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 3
- States / cities
- Hackensack, New Jersey • Ridgewood, New Jersey • New York, New York
- Conditions
- Gastroesophageal Reflux, Apnea, Bradycardia
- Interventions
- Erythromycin, Multi-channel intra-luminal impedance (MII) pH monitoring, Placebo (D5W)
- Drug · Device
- Lead sponsor
- University of Virginia
- Other
- Eligibility
- 14 Days and older
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2014
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
- Conditions
- Prematurity
- Interventions
- Apparatuses
- Device
- Lead sponsor
- University of Oklahoma
- Other
- Eligibility
- Up to 20 Minutes
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011
- U.S. locations
- 1
- States / cities
- Oklahoma City, Oklahoma
- Conditions
- Premature Birth of Newborn
- Interventions
- Kangaroo Care
- Other
- Lead sponsor
- Case Western Reserve University
- Other
- Eligibility
- 7 Days to 37 Weeks
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2015
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Intestinal Blood Flow
- Interventions
- ultrasound
- Procedure
- Lead sponsor
- St. Louis University
- Other
- Eligibility
- Up to 3 Months
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Prematurity, Respiratory Distress Syndrome, Patent Ductus Arteriosus
- Interventions
- Survanta (beractant), Curosurf (poractant)
- Drug
- Lead sponsor
- Alan Fujii
- Other
- Eligibility
- Up to 8 Hours
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Myocarditis, Premature Ventricular Contractions, Ventricular Tachycardia (VT)
- Interventions
- Not listed
- Lead sponsor
- Kansas City Heart Rhythm Research Foundation
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 1
- States / cities
- Overland Park, Kansas
- Conditions
- Patent Ductus Arteriosus
- Interventions
- Early ibuprofen, Late ibuprofen expectant group (placebo)
- Drug · Other
- Lead sponsor
- University of Miami
- Other
- Eligibility
- 1 Day to 14 Days
- Enrollment
- 105 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2011
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Turner Syndrome, Post-menarcheal Adolescents, Ovarian Disfunction, Galactosemia, Variations in Sex Characteristics, Differences in Sex Development
- Interventions
- Not listed
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Eligibility
- 2 Years to 35 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2030
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Ventricular Premature Beats, Contractions, or Systoles, Cardiomyopathies
- Interventions
- Radiofrequency ablation, Amiodarone (Antiarrhythmic drug)
- Procedure · Drug
- Lead sponsor
- Hunter Holmes Mcguire Veteran Affairs Medical Center
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 10
- States / cities
- Los Angeles, California • San Francisco, California • Tampa, Florida + 6 more
- Conditions
- Ventricular Premature Complexes, Myocardial Ischemia
- Interventions
- ranolazine
- Drug
- Lead sponsor
- Kent Hospital, Rhode Island
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2018
- U.S. locations
- 1
- States / cities
- Warwick, Rhode Island
- Conditions
- Patent Ductus Arteriosus
- Interventions
- Ibuprofen
- Drug
- Lead sponsor
- Taipei Medical University Hospital
- Other
- Eligibility
- Up to 6 Months
- Enrollment
- 110 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2012
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Indication for Peripheral Intravenous Catheterization, Atrial Flutter, Premature Atrial Contraction, Premature Ventricular Contraction, Premature Junctional Contraction, Tachycardia, Atrioventricular Block, Bundle-Branch Block
- Interventions
- PICC placement with SHERLOCK 3CG™ Diamond TCS with MODUS II software
- Procedure
- Lead sponsor
- C. R. Bard
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 232 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 6
- States / cities
- Las Vegas, Nevada • Greensboro, North Carolina • Greenville, North Carolina + 3 more
- Conditions
- Ventricular Tachycardia (VT), Premature Ventricular Complexes
- Interventions
- Not listed
- Lead sponsor
- University Hospital, Basel, Switzerland
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 15,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 2
- States / cities
- Chicago, Illinois • Michigan Center, Michigan
- Conditions
- Premature Infant, Extremely Low Birth Weight, Extreme Prematurity
- Interventions
- iRes Warmer with ResusView, iRes Warmer without ResusView
- Device · Other
- Lead sponsor
- Sharp HealthCare
- Other
- Eligibility
- 23 Weeks to 32 Weeks
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Patent Ductus Arteriosus, Neonate
- Interventions
- Acetaminophen, ibuprofen
- Drug
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 23 Weeks to 30 Weeks
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 2
- States / cities
- Jacksonville, Florida
- Conditions
- Patent Ductus Arteriosus, Preterm Infant, Bronchopulmonary Dysplasia, Neurodevelopmental Abnormality
- Interventions
- Not listed
- Lead sponsor
- Nationwide Children's Hospital
- Other
- Eligibility
- Up to 72 Hours
- Enrollment
- 526 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2026
- U.S. locations
- 4
- States / cities
- Columbus, Ohio
- Conditions
- Heart Rate Variability, Preterm Infant
- Interventions
- Skin to Skin
- Other
- Lead sponsor
- University of New Mexico
- Other
- Eligibility
- 1 Day to 6 Weeks
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- Albuquerque, New Mexico
- Conditions
- Patent Ductus Arteriosus
- Interventions
- Not listed
- Lead sponsor
- University of Utah
- Other
- Eligibility
- Up to 3 Months
- Enrollment
- 350 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2014
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Premature Ventricular Contractions, Congestive Heart Failure
- Interventions
- PVC ablation
- Device
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2017
- U.S. locations
- 7
- States / cities
- Los Angeles, California • Baltimore, Maryland • Boston, Massachusetts + 3 more
- Conditions
- Patent Ductus Arteriosus, Surgery, Necrotizing Enterocolitis, Intestinal Perforation
- Interventions
- pharmacologic treatment of the PDA, no pharmacologic treatment of the PDA, NSAID
- Other · Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 5 Days to 14 Days
- Enrollment
- 202 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2017
- U.S. locations
- 13
- States / cities
- San Diego, California • San Francisco, California • San Jose, California + 9 more